Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial.
about
Persistence and adherence with dementia pharmacotherapy: relevance of patient, provider, and system factorsThe feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Long-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012.Pharmacologic management of behavioral and psychological symptoms of major neurocognitive disorder
P2860
Cessation versus continuation of galantamine treatment after 12 months of therapy in patients with Alzheimer's disease: a randomized, double blind, placebo controlled withdrawal trial.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Cessation versus continuation ...... o controlled withdrawal trial.
@en
Cessation versus continuation ...... o controlled withdrawal trial.
@nl
type
label
Cessation versus continuation ...... o controlled withdrawal trial.
@en
Cessation versus continuation ...... o controlled withdrawal trial.
@nl
prefLabel
Cessation versus continuation ...... o controlled withdrawal trial.
@en
Cessation versus continuation ...... o controlled withdrawal trial.
@nl
P2093
P356
P1476
Cessation versus continuation ...... o controlled withdrawal trial.
@en
P2093
Adam Jacobs
Barbara Schäuble
Giuseppe Zappalà
Maren Gaudig
Marina Adami
Ute Richarz
P304
P356
10.3233/JAD-2011-110134
P577
2011-01-01T00:00:00Z